16-07-2026 17:45 via drugs.com

Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum

THURSDAY, July 16, 2026-- Postpartum breast cancer (PPBC) diagnosed within the first year postpartum has a significantly elevated 21-gene Oncotype DX Recurrence Score (RS), according to a study published online July 1 in npj Breast Cancer.Shiliang...

AAIC: Blood Test Detecting p-tau217 Levels Can Predict Progression to Cognitive Impairment

AAIC: Blood-Based Biomarkers for Alzheimer Disease Improve Accuracy of Diagnosis

Peptide Vaccine Targeting KRAS Mutations Promising for Pancreatic Ductal Adenocarcinoma

Seniors Undergoing High-Risk Emergency General Surgery Have Fewer Healthy Days at Home

Tobacco Treatment Program Effective in Oncology Settings

Odds of Stroke Lower Among Black Individuals Who Have Immigrated

New Cancer Cases Predicted to Increase to 34.4 Million by 2050

About One-Third of Women 35 Years and Older Report Perimenopause Uncertainty

Increase in Smoking Unlikely With Very Low Nicotine Cigarettes

High-Dose Intravenous Vitamin C May Benefit Trauma Patients

GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes

Global Findings Indicate Breast Cancer and A-Fib Incidence Frequently Overlap

GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy

Epidural Analgesia in Labor Appears to Be Safe for Newborns

Desktop versie

Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum

Pharmaceutical Industry news